Literature DB >> 18927510

The cullin7 E3 ubiquitin ligase: a novel player in growth control.

Antonio Sarikas1, Xinsong Xu, Loren J Field, Zhen-Qiang Pan.   

Abstract

Cullin7 (CUL7) is a molecular scaffold that organizes an E3 ubiquitin ligase containing the F-box protein Fbw8, Skp1 and the ROC1 RING finger protein. Dysregulation of the CUL7 E3 Ligase has been directly linked to hereditary human diseases as cul7 germline mutations were found in patients with autosomal-recessive 3-M and Yakuts short stature syndromes, which are characterized by profound pre- and postnatal growth retardation. In addition, genetic ablation of CUL7 in mice resulted in intrauterine growth retardation and perinatal lethality, underscoring its importance for growth regulation. The recent identification of insulin receptor substrate 1, a critical mediator of insulin and insulin-like growth factor-1 signaling, as the proteolytic target of the CUL7 E3 ligase, provided a molecular link between CUL7 and a well-established growth regulatory pathway. This result, coupled with other studies demonstrating interactions between CUL7 and the p53 tumor suppressor protein, as well as the simian virus 40 large T antigen oncoprotein, further implicated CUL7 as a novel player in growth control and suggested pathomechanistic insights into CUL7-linked growth retardation syndromes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927510      PMCID: PMC2637179          DOI: 10.4161/cc.7.20.6922

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  80 in total

1.  A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor.

Authors:  M J E Walenkamp; H J van der Kamp; A M Pereira; S G Kant; H A van Duyvenvoorde; M F Kruithof; M H Breuning; J A Romijn; M Karperien; J M Wit
Journal:  J Clin Endocrinol Metab       Date:  2006-06-06       Impact factor: 5.958

Review 2.  Oncogene-induced cell senescence--halting on the road to cancer.

Authors:  W J Mooi; D S Peeper
Journal:  N Engl J Med       Date:  2006-09-07       Impact factor: 91.245

3.  Stops along the RAS pathway in human genetic disease.

Authors:  Mohamed Bentires-Alj; Maria I Kontaridis; Benjamin G Neel
Journal:  Nat Med       Date:  2006-03       Impact factor: 53.440

4.  Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction.

Authors:  Carole S Watson; Peter Bialek; Makoto Anzo; Javad Khosravi; Siu-Pok Yee; Victor K M Han
Journal:  Endocrinology       Date:  2005-11-17       Impact factor: 4.736

5.  Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development.

Authors:  Ryosuke Tsunematsu; Masaaki Nishiyama; Shuhei Kotoshiba; Toru Saiga; Takumi Kamura; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

6.  Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.

Authors:  Janet L Martin; Robert C Baxter
Journal:  Endocrinology       Date:  2007-02-08       Impact factor: 4.736

7.  Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.

Authors:  P Andrews; Y J He; Y Xiong
Journal:  Oncogene       Date:  2006-03-20       Impact factor: 9.867

8.  Induction of cullin 7 by DNA damage attenuates p53 function.

Authors:  Peter Jung; Berlinda Verdoodt; Aaron Bailey; John R Yates; Antje Menssen; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

9.  Identification of mutations in CUL7 in 3-M syndrome.

Authors:  Céline Huber; Dora Dias-Santagata; Anna Glaser; James O'Sullivan; Raja Brauner; Kenneth Wu; Xinsong Xu; Kerra Pearce; Rong Wang; Maria Luisa Giovannucci Uzielli; Nathalie Dagoneau; Wassim Chemaitilly; Andrea Superti-Furga; Heloisa Dos Santos; André Mégarbané; Gilles Morin; Gabriele Gillessen-Kaesbach; Raoul Hennekam; Ineke Van der Burgt; Graeme C M Black; Peter E Clayton; Andrew Read; Martine Le Merrer; Peter J Scambler; Arnold Munnich; Zhen-Qiang Pan; Robin Winter; Valérie Cormier-Daire
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

Review 10.  The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention.

Authors:  John P Alao
Journal:  Mol Cancer       Date:  2007-04-02       Impact factor: 27.401

View more
  26 in total

Review 1.  Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.

Authors:  Nicole F Villeneuve; Alexandria Lau; Donna D Zhang
Journal:  Antioxid Redox Signal       Date:  2010-08-14       Impact factor: 8.401

2.  The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.

Authors:  Monica Cubillos-Rojas; Fabiola Amair-Pinedo; Roser Peiró-Jordán; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

3.  FBG1 is a promiscuous ubiquitin ligase that sequesters APC2 and causes S-phase arrest.

Authors:  Hsiang Wen; Namhun Kim; Ernesto J Fuentes; Adam Mallinger; Pedro Gonzalez-Alegre; Kevin A Glenn
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

4.  Ubiquitin-dependent proteolysis in G1/S phase control and its relationship with tumor susceptibility.

Authors:  J Alan Diehl; Bhaskar Ponugoti
Journal:  Genes Cancer       Date:  2010-07-01

5.  Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.

Authors:  Thomas Hartmann; Xinsong Xu; Mira Kronast; Susanne Muehlich; Kathleen Meyer; Wolfgang Zimmermann; Jerard Hurwitz; Zhen-Qiang Pan; Stefan Engelhardt; Antonio Sarikas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 6.  Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2).

Authors:  Michael A Destefano; Estela Jacinto
Journal:  Biochem Soc Trans       Date:  2013-08       Impact factor: 5.407

Review 7.  The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications.

Authors:  Pascal Genschik; Izabela Sumara; Esther Lechner
Journal:  EMBO J       Date:  2013-08-02       Impact factor: 11.598

Review 8.  The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.

Authors:  Jordan Blondelle; Andrea Biju; Stephan Lange
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

9.  SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Authors:  Jinfang Zhang; Ming Chen; Yasheng Zhu; Xiangpeng Dai; Fabin Dang; Junming Ren; Shancheng Ren; Yulia V Shulga; Francisco Beca; Wenjian Gan; Fei Wu; Yu-Min Lin; Xiaobo Zhou; James A DeCaprio; Andrew H Beck; Kun Ping Lu; Jiaoti Huang; Cheryl Zhao; Yinghao Sun; Xu Gao; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Dev Cell       Date:  2018-12-27       Impact factor: 12.270

Review 10.  Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.

Authors:  Zhen-Qiang Pan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.